Sobre Mind the Byte
Computational drug discovery can reduce development time and costs for new drugs by up to 30%, and in 2016 it is expected to represent 20% of total global RD&I expenditure in pharma companies.
Mind the Byte offers a pay-per-use SaaS platform (software as a service) with latest generation software (Cabrakan, Hurakan and Ixchel) that, starting from a molecule (SDF or SMILE file), allows users to predict which proteins it will interact with as well as its therapeutic indications in only minutes.
This platform was developed by Mind the Byte to break through the most important technological and economic barriers of computational design for companies and research centres
Galería Mind the Byte 0
Mind the Byte no tiene ninguna imágen en su galería.
Equipo Mind the Byte 0
Mind the Byte no tiene a su equipo agregado
Inversores Mind the Byte 2
Acceleradoras Mind the Byte 1